Expression profile analysis of long non ‐coding RNA in acute myeloid leukemia by microarray and bioinformatics

Long non‐coding RNAs (lncRNAs) are transcripts longer than 200 nt that are involved in tumorigenesis and play a key role in cancer progression. To determine whether lncRNAs are involved in acute myeloid leukemia (AML), we analyzed the expression profile of lncRNAs and mRNAs in AML. Five pairs of AML patients and iron deficiency anemia (IDA) controls were screened by microarray. Through coexpression analysis, differently expressed transcripts were divided into modules, and lncRNAs were functionally annotated. We further analyzed the clinical significance of crucial lncRNAs from modules in public data. Finally, the expression of three lncRNAs, RP11‐222K16.2, AC092580.4, and RP11‐305O.6, were validated in newly diagnosed AML, AML relapse, and IDA patient groups by quantitative RT‐PCR, which may be associated with AML patients’ overall survival. Further analysis showed that RP11‐222K16.2 might affect the differentiation of natural killer cells, and promote the immunized evasion of AML by regulating Eomesodermin expression. Analysis of this study revealed that dysregulated lncRNAs and mRNAs in AML vs IDA controls could affect the immune system and hematopoietic cell differentiation. The biological functions of those lncRNAs need to be further validated. We analyzed the expression profiles of lncRNAs and mRNAs in AML (acute myeloid leukemia). Bioinformatics were applied to find the important transcripts and confirm the prognostic significant of lncRNAs. We validated 2 ...
Source: Cancer Science - Category: Cancer & Oncology Authors: Tags: ORIGINAL ARTICLE Source Type: research